Cargando…

Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis

Liposomal-amphotericin B (L-AmB) is used for cutaneous leishmaniasis (CL); however, its treatment failure has not yet been described in detail. A 58-year-old man returned from the Republic of Venezuela with a cutaneous ulcer on his left lower leg. The causative pathogen was Leishmania braziliensis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosaka, Atsushi, Sakamoto, Naoya, Hikone, Mayu, Imai, Kazuo, Ota, Masayuki, Washino, Takuya, Maeda, Takuya, Iwabuchi, Sentarou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270753/ https://www.ncbi.nlm.nih.gov/pubmed/32378656 http://dx.doi.org/10.2169/internalmedicine.4096-19

Ejemplares similares

Therapy of cutaneous leishmaniasis caused by Leishmania braziliensis with fluconazole
por: Veraldi, Stefano, et al.
Publicado: (2021)

Critically ill patients with COVID-19 in Tokyo, Japan: A single-center case series
por: Miike, Satoshi, et al.
Publicado: (2021)

Outbreak of Leishmania braziliensis Cutaneous Leishmaniasis, Saül, French Guiana
por: Martin-Blondel, Guillaume, et al.
Publicado: (2015)

Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil
por: Membrive, Norberto Assis, et al.
Publicado: (2017)

Rhinophyma-Like Cutaneous Leishmaniasis due to Leishmania aethiopica Treated Successfully with Liposomal Amphotericin B
por: Kirchberger, Michael Constantin, et al.
Publicado: (2019)

Characterization of Neutrophil Function in Human Cutaneous Leishmaniasis Caused by Leishmania braziliensis
por: Conceição, Jacilara, et al.
Publicado: (2016)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

COVID-19-associated leukoencephalopathy in the absence of severe hypoxia with subsequent improvement: a case report
por: Kojima, Hiroki, et al.
Publicado: (2022)

Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
por: Solomon, Michal, et al.
Publicado: (2019)

Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis
por: Santos, Diego M., et al.
Publicado: (2014)

Therapeutic Efficacy of Arnica in Hamsters with Cutaneous Leishmaniasis Caused by Leishmania braziliensis and L. tropica
por: Robledo, Sara M., et al.
Publicado: (2022)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Guerra, Jorge Augusto de Oliveira, et al.
Publicado: (2011)

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
por: Guery, Romain, et al.
Publicado: (2017)

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient
por: Zauli, Rogéria C, et al.
Publicado: (2012)

Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial
por: Machado, Paulo R., et al.
Publicado: (2010)

Canine Cutaneous Leishmaniasis: Dissemination and Tissue Tropism of Genetically Distinct Leishmania (Viannia) braziliensis Populations
por: de Oliveira, Guilherme Marx, et al.
Publicado: (2013)

Nosocomial outbreak of coronavirus disease in two general wards during the initial wave of the pandemic in 2020,  Tokyo, Japan
por: Sakamoto, Naoya, et al.
Publicado: (2022)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis
por: Giudice, Angela, et al.
Publicado: (2007)

Leishmania braziliensis isolated from disseminated leishmaniasis patients downmodulate neutrophil function
por: Cardoso, Thiago, et al.
Publicado: (2019)

The Influence of Infection by Different Leishmania (Viannia) braziliensis Isolates on the Pathogenesis of Disseminated Leishmaniasis
por: Oliveira, Walker N., et al.
Publicado: (2021)

Dogs Harbor Leishmania braziliensis and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis
por: Lago, Jamile, et al.
Publicado: (2023)

GENOTYPE CHARACTERIZATION OF Leishmania (Viannia) braziliensis ISOLATED FROM HUMAN AND CANINE BIOPSIES WITH AMERICAN CUTANEOUS LEISHMANIASIS
por: FERREIRA, Lasaro Teixeira, et al.
Publicado: (2015)

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects
por: Guimarães, Luiz Henrique, et al.
Publicado: (2016)

Leishmania (Viannia) braziliensis type 2 as probable etiological agent of canine cutaneous leishmaniasis in Brazilian Amazon
por: Brilhante, Andreia Fernandes, et al.
Publicado: (2019)

962. Cutaneous Leishmaniasis: Investigating Skin Drug Levels to Optimize Liposomal Amphotericin Dosing
por: Aronson, Naomi E, et al.
Publicado: (2018)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment
por: Borges, Ana Flávia, et al.
Publicado: (2021)

Non-serogroupable Neisseria meningitidis pneumonia in an immunocompetent patient with severe COVID-19 pneumonia: A case report
por: Kojima, Hiroki, et al.
Publicado: (2022)

A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report
por: Nakamura, Kazuha, et al.
Publicado: (2020)

The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis
por: Carneiro, Pedro Paulo, et al.
Publicado: (2016)

Severe Cutaneous Leishmaniasis in a Human Immunodeficiency Virus Patient Coinfected with Leishmania braziliensis and Its Endosymbiotic Virus
por: Parmentier, Laurent, et al.
Publicado: (2016)

Leishmania (Viannia) braziliensis isolated from the saliva of patients in a cutaneous leishmaniasis-endemic area of northeastern Brazil
por: de Brito, Maria Edileuza Felinto, et al.
Publicado: (2018)

Unveiling drug-tolerant and persister-like cells in Leishmania braziliensis lines derived from patients with cutaneous leishmaniasis
por: Jara, Marlene, et al.
Publicado: (2023)

Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs
por: Lago, Jamile, et al.
Publicado: (2019)

The immunobiology of Leishmania braziliensis infection
por: de Oliveira, Camila I., et al.
Publicado: (2012)

Dogs as Reservoirs for Leishmania braziliensis
por: Dantas-Torres, Filipe
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_arbo7o4uog2iqdimeq92mgfgl3